AI in Healthcare Supply Chains: The Overlooked Solution to Drug Shortages and Administrative Burden

Every week, I speak with pharmacy directors and supply chain leaders at health systems across the country. Almost universally, they share a common frustration: they spend more time chasing inventory than taking care of patients. This structural failure is costing the industry far more than most executives realize.

Drug shortages alone cost U.S. Hospitals an estimated $900 million and 20 million labor hours annually, according to a June 2025 survey from Vizient. These figures only cover direct financial and staffing burdens; they don’t account for additional costs like more expensive alternative drugs, emergency sourcing premiums, or the erosion of pharmacist capacity when skilled clinicians are bogged down by shortage workarounds.

The Hidden Costs of Manual Inventory Management

Pharmacy teams manage thousands of drug SKUs across dozens or hundreds of locations. Each SKU comes with expiration dates, lot numbers, regulatory controls, and storage requirements. Many of these locations-such as IV rooms, compounding areas, hazardous drug zones, and satellite pharmacies-operate in relative informational isolation. Healthcare leaders often lack real-time, system-wide visibility into pharmacy inventory, leaving them unprepared to manage major disruptions.

Two decades into the electronic medical record (EMR) era, most pharmacy supply chains are still running on fragmented systems, manual counts, institutional knowledge, and software not designed for today’s complex operational environment. When something goes wrong, teams resort to old methods: calling around, checking spreadsheets, contacting suppliers, and escalating issues.

AI has the potential to transform this landscape by automating inventory management, providing real-time data, and optimizing workflows. By reducing administrative burden and redesigning processes around human needs, AI can create space for what matters most: the connection between clinicians and patients.

The Human Cost

The impact of these inefficiencies extends beyond financial costs. Pharmacists are being set up for failure when they must juggle thousands of drug SKUs and manage shortages with outdated tools. This not only affects their job satisfaction but also patient care. When skilled clinicians spend hours on shortage workarounds, it detracts from the time they could be spending directly with patients.

The stress and burnout caused by these inefficiencies can lead to higher turnover rates among pharmacy staff. This exacerbates staffing shortages, further straining healthcare systems. By implementing AI solutions, hospitals can alleviate some of this pressure, allowing pharmacists to focus on what they do best: ensuring patient safety and well-being.

The transition to AI in healthcare supply chains is not just a technological upgrade; it’s a necessary step toward improving patient outcomes and the overall efficiency of our healthcare system. As we move forward, it’s crucial that we prioritize investments in these technologies to create a more resilient and responsive healthcare environment.